» Articles » PMID: 12604533

Comparing Pharmacokinetics of Amoxicillin Given Twice or Three Times Per Day to Children Older Than 3 Months with Pneumonia

Overview
Specialty Pharmacology
Date 2003 Feb 27
PMID 12604533
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

For children with ambulatory pneumonia, the World Health Organization (WHO) recommends oral amoxicillin (15 mg/kg of body weight/dose) thrice daily (t.i.d.) or oral cotrimoxazole (4 mg of trimethoprim/kg/dose) twice daily (b.i.d.). The more frequent amoxicillin dosing may lead to compliance problems. To compare the pharmacokinetics and levels of amoxicillin in plasma in the current WHO acute respiratory infection recommendations with the 25-mg/kg/dose b.i.d. regimen, we performed a two-group parallel study of 66 children ages 3 to 59 months with pneumonia. Amoxicillin was given orally at 25 mg/kg/dose b.i.d. or 15 mg/kg/dose t.i.d. Amoxicillin concentrations were determined by high-performance liquid chromatography after the first dose on days 1 and 3. After the first dose on day 1, the mean area under the concentration-time curve (AUC) for amoxicillin after the 25-mg/kg dose was 54.7 versus 24.9 micro g. h/ml after the 15-mg/kg dose. After the first dose on day 3, the mean AUC was 44.1 versus 28.5 micro g. h/ml. All but two children had plasma amoxicillin concentrations above 0.5 micro g/ml for >50% of the dose interval on both days. Six children on day 1 and five children on day 3 had concentrations above 1.0 micro g/ml for <50% of the dose interval. On day 1, 16 of 27 children in the b.i.d. group and 11 of 26 children in the t.i.d. group had concentrations that were above 2.0 micro g/ml for <50% of the dose interval, and on day 3, 18 of 31 children in the b.i.d. group and 8 of 31 children in the t.i.d. group had concentrations that were above 2.0 micro g/ml for <50% of the dose interval. Amoxicillin b.i.d. is a feasible alternative for t.i.d. dosing. To lengthen the time above the MIC at higher concentration levels, a 30- to 40-mg/kg/dose b.i.d. should be considered instead of the 25 mg/kg/dose used in this study.

Citing Articles

Antibiotic route and outcomes for children hospitalized with pneumonia.

Cotter J, Hall M, Neuman M, Blaschke A, Brogan T, Cogen J J Hosp Med. 2024; 19(8):693-701.

PMID: 38678444 PMC: 11332399. DOI: 10.1002/jhm.13382.


Short-Course vs Long-Course Antibiotic Therapy for Children With Nonsevere Community-Acquired Pneumonia: A Systematic Review and Meta-analysis.

Li Q, Zhou Q, Florez I, Mathew J, Shang L, Zhang G JAMA Pediatr. 2022; 176(12):1199-1207.

PMID: 36374480 PMC: 9664370. DOI: 10.1001/jamapediatrics.2022.4123.


Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial.

Shahrin L, Chisti M, Shahid A, Rahman A, Islam M, Afroze F JMIR Res Protoc. 2020; 9(11):e17735.

PMID: 33136058 PMC: 7669443. DOI: 10.2196/17735.


Colonization of Mice With Amoxicillin-Associated Drives Inflammation via Th1 Induction and Treg Inhibition.

Lin H, Wang Q, Liu L, Chen Z, Das R, Zhao Y Front Microbiol. 2020; 11:1256.

PMID: 32670220 PMC: 7326774. DOI: 10.3389/fmicb.2020.01256.


Long-Term Effects of Early-Life Antibiotic Exposure on Resistance to Subsequent Bacterial Infection.

Roubaud-Baudron C, Ruiz V, Swan Jr A, Vallance B, Ozkul C, Pei Z mBio. 2019; 10(6).

PMID: 31874917 PMC: 6935859. DOI: 10.1128/mBio.02820-19.


References
1.
Ginsburg C, McCracken Jr G, Thomas M, Clahsen J . Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children. Pediatrics. 1979; 64(5):627-31. View

2.
Daschner F, Behre U, Dalhoff A . Prospective clinical trial on the efficacy of amoxycillin administered twice or four times daily in children with respiratory tract infections. J Int Med Res. 1981; 9(4):274-6. DOI: 10.1177/030006058100900407. View

3.
Foulstone M, Reading C . Assay of amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high-performance liquid chromatography. Antimicrob Agents Chemother. 1982; 22(5):753-62. PMC: 185656. DOI: 10.1128/AAC.22.5.753. View

4.
Deeks S, Palacio R, Ruvinsky R, Kertesz D, Hortal M, Rossi A . Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. Pediatrics. 1999; 103(2):409-13. DOI: 10.1542/peds.103.2.409. View

5.
CHRETIEN J, Holland W, MACKLEM P, Murray J, Woolcock A . Acute respiratory infections in children. A global public-health problem. N Engl J Med. 1984; 310(15):982-4. DOI: 10.1056/NEJM198404123101509. View